RxDoctor Payments Data

Guatemala Kimble

Family · Smyrna, GANPI 1427593326

Payments from drug & device makers

$1,875in general payments, 2019–2025

Across 144 payments — averaging $13.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$605
  • Takeda Pharmaceuticals U.S.A., Inc.$198
  • Ardelyx, Inc.$189
  • Nestle Healthcare Nutrition Inc.$183
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$173
  • Phathom Pharmaceuticals, Inc.$81
  • plus $446 from 12 others

What the payments were for

  • Food & beverage$1,875100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,875 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$53,357
Medicare patients
463
Services billed
670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide33$27,608
TrulancePlecanatide11$8,387
AprisoMesalamine15$7,900
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates112$7,034
CholestyramineCholestyramine (With Sugar)82$4,711
Dexlansoprazole DrDexlansoprazole14$4,425
ClenpiqSod Picosulf/Mag Ox/Citric Ac22$3,758
Budesonide EcBudesonide12$3,102
Pantoprazole Sodium171$2,092
Budesonide DrBudesonide27$2,029
Esomeprazole Magnesium62$1,590
Omeprazole87$1,455
Dicyclomine Hcl79$1,166
Famotidine67$1,123
Ondansetron OdtOndansetron26$854

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$605$27,60833 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance, Apriso$173$16,28726 claims
Ferring Pharmaceuticals Inc.Clenpiq$14$3,75822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.

Other family in Smyrna

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →